SCHEMBL2469758

SCHEMBL2469758

COc1ccc(F)c(C(=O)NC2CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.51
RAB9A P51151 4/20 0.51
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 2/20 0.51
HTR4 Q13639 1/20 0.51
SMYD3 Q9H7B4 1/20 0.51
HSD17B10 Q99714 1/20 0.51
HPGDS O60760 2/20 0.50
KDM1A O60341 1/20 0.50
MAOA P21397 1/20 0.50
KLK7 P49862 1/20 0.49
POLB P06746 2/20 0.49
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRA2 P47869 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 2/20 0.48
CNR1 P21554 1/20 0.48
CNR2 P34972 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29535889 0.90 MCHR1 (0.50) HPGDRAB9AALDH1A1KDM4EHTR4
SCHEMBL30804736 0.86 PARP1 (0.52) HPGDRAB9AALDH1A1KDM4EHTR4
SCHEMBL30804723 0.86 HPGDS (0.58) HPGDRAB9AALDH1A1KDM4EHTR4
SCHEMBL30938319 0.85 HTR4 (0.50) HPGDRAB9AALDH1A1KDM4EHTR4
SCHEMBL4218063 0.81 RAB9A (0.63) HPGDRAB9AALDH1A1KDM4EHTR4
SCHEMBL30923207 0.80 HTR4 (0.47) HPGDRAB9AALDH1A1KDM4EHTR4
SCHEMBL16548437 0.80 TAS1R3 (0.58) HPGDRAB9AALDH1A1HSD17B10KDM1A
SCHEMBL30479219 0.79 DYRK1A (0.46) HPGDSCNR2MCHR1
SCHEMBL25213585 0.78 CA1 (0.54) RAB9AALDH1A1KDM4EHSD17B10POLB
SCHEMBL30001821 0.78 CYP1A2 (0.49) RAB9AALDH1A1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501830-B1 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES ACTELION PHARMACEUTICALS LTD (CH) 2011-10-05 EP claimed
EP-1786814-B1 BICYCLONONENE DERIVATIVES AS RENIN INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2010-03-31 EP claimed
EP-1620403-B1 NOVEL 3,4-DISUBSTITUTED 1,2,3,6-TETRAHYDROPYRIDINE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2007-11-28 EP claimed